Logo

Prolexys and Ariadne to Integrate Software, Database

Nov 16, 2005

NEW YORK, Nov. 16 (GenomeWeb News) - Ariadne Genomics and Prolexys Pharmaceuticals will pair their pathway-analysis tools to target the pharmaceutical research market, the companies said today

 

Under the terms of the agreement, Prolexys' Human Interactome Database, a collection of experimentally verified human protein-protein interactions, will be integrated with Ariadne's PathwayStudio and PathwayExpert pathway-analysis software.


The Prolexys database will be available from Ariadne Genomics for an additional fee to its commercial customers, Prolexys and Ariadne said.

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.